Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation | Zendy

Johanna Pennlert | Zendy; Rosanna Overholser | Zendy; Kjell Asplund | Zendy; Bo Carlberg | Zendy; Bart Van Rompaye | Zendy; Per-Gunnar Wiklund | Zendy; Marie Eriksson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation

Author(s) -

Johanna Pennlert,

Rosanna Overholser,

Kjell Asplund,

Bo Carlberg,

Bart Van Rompaye,

Per-Gunnar Wiklund,

Marie Eriksson

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.014643

Subject(s) - medicine , atrial fibrillation , intracerebral hemorrhage , antithrombotic , stroke (engine) , anticoagulant , confidence interval , incidence (geometry) , cardiology , cumulative incidence , relative risk , comorbidity , observational study , cohort , subarachnoid hemorrhage , mechanical engineering , physics , optics , engineering

This study aims to provide observational data on the relationship between the timing of antithrombotic treatment and the competing risks of severe thrombotic and hemorrhagic events in a cohort of Swedish patients with atrial fibrillation and intracerebral hemorrhage (ICH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research